A 70-year-old man with CKD G4, osteoporosis and low bone turnover 

Do you use anabolic therapy in patients with CKD? Visit the webcast of the EUROD clinical-pathological case discussion on November 14 2024 to learn more!

The clinical case was presented by Prof. Ditte Hansen and Prof. Thomas Levin Andersen from Denmark , and discussed with prof. Dr. Renate de Jongh from the Netherlands, Dr. Susa Lloret from Spain and Prof. Pieter Evenepoel from Belgium.

Case description: Teriparatide (PTH1-34) is a potent osteoanabolic drug registered for use in cases of severe osteoporosis. Osteoanabolic therapy may also benefit patients with advanced CKD and low bone turnover. This e-seminar discusses the therapeutic options for a patient with CKDG4, osteoporosis and low bone turnover, and the benefits of 18 months of treatment with teriparatide.  

Watch the webcast here: www.era-online.org/video-pages/a-70-year-old-man-with-ckd-g4-osteoporosis-and-low-bone-turnover/